CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 261,006	$ 87,514
Short-term investments	146,424	280,660
Prepaid expenses and other current assets	11,261	6,225
Total current assets	418,691	374,399
Property and equipment, net	33,770	25,977
Deferred tax assets	4,827	768
Other non-current assets	16,687	4,669
Total non-current assets	55,284	31,414
Total assets	473,975	405,813
Current liabilities:
Accounts payable	24,419	11,957
Accrued expenses and other payables	22,427	22,297
Tax payable	3,106	804
Total current liabilities	49,952	35,058
Non-current liabilities:
Long-term bank loan	17,701	17,284
Shareholder loan	135,027
Other long-term liabilities	1,123	564
Total non-current liabilities	153,851	17,848
Total liabilities	203,803	52,906
Commitments and contingencies
Equity:
Ordinary shares (par value of US$0.0001 per share; 9,500,000,000 shares authorized; 518,902,349 shares issued and outstanding as of June 30, 2017 (December 31, 2016: 9,500,000,000 shares authorized; 515,833,609 shares issued and outstanding))	52	52
Additional paid-in capital	604,603	591,213
Accumulated other comprehensive loss	(322)	(946)
Accumulated deficit	(348,580)	(237,412)
Total BeiGene, Ltd. shareholders' equity	255,753	352,907
Noncontrolling interest	14,419
Total equity	270,172	352,907
Total liabilities and equity	$ 473,975	$ 405,813